As of today, Health Insurance coverage of coronavirus screening tests is changing.
- As of March 1, Covid-19 screening tests will no longer be fully reimbursed for all vaccinated people.
- Minors, those over 65, French people benefiting from long and expensive treatment, caregivers, immunocompromised patients and people participating in collective screening are not affected by these new methods.
- A moderating ticket, ie a remainder to be paid, is introduced in the context of carrying out a screening test. It is determined according to the healthcare professional issuing it.
According to a decree, published in Official newspaper this Tuesday, the reimbursement rules for Covid-19 screening tests are changing in mainland France and in all overseas departments and regions. 100% coverage by Health Insurance of tests for all vaccinated people, without medical prescription, ends on March 1, 2023.
From this date, “a co-payment, that is to say a remainder payable by the insured, applies to the Covid-19, PCR and serological screening tests. It concerns all the insured, with the exception of some who will continue to benefit from 100% reimbursement of their Covid-19 test due to an exemption linked to their situation”, explains the Health Insurance on his website.
The co-payment is determined according to the practitioner delivering the Covid test
According the government, the remaining charge for the insured is determined according to the health professional delivering the test. The insured will have to pay 30% of the cost of the test if it is carried out by a doctor or a pharmacist and 40% if it is carried out by a nurse or a physiotherapist. “In the vast majority of cases, the covid-19 test co-payment is fully reimbursed by mutual or complementary health insurance”, says health insurance.
Covid test: who will continue to benefit from a full refund?
To continue to protect the most vulnerable French people who are likely to develop a serious form of the coronavirus, 100% coverage is maintained for:
- People recognized as having a long-term illness (ALD)
- People aged 65 and over
- Young people under the age of 18
- Health professionals and their employees and people working in a health establishment or in a social or medico-social service
- Immunocompromised patients
- People undergoing organized collective screening
Advertisement
